Hippo pathway activation drives fibrogenic remodeling in influenza a virus–infected lung fibroblasts

Background Pulmonary fibrosis is a progressive and often fatal interstitial lung disease with largely undefined etiology. Alveolar macrophages and lung fibroblasts play key roles in maladaptive tissue remodeling; however, the cellular and molecular mechanisms underlying their coordinated fibrotic responses remain incompletely characterized. Methods Following IAV infection, viral load, cytokine release, and transcriptomic changes were analysed. To assess indirect effects on fibrosis, IMR-90 fibroblasts were treated with conditioned media from infected AML cells. Direct IAV infection of IMR-90 cells was also performed to evaluate changes in the Hippo signalling pathway and fibrotic marker expression using microarray and transcriptomic approaches. Results For the first time, AML cells were successfully infected with IAV, validating this model for studying pathogen-driven exacerbation of fibrosis in aging lungs. Transcriptomic and protein-level analyses revealed that IAV promotes fibrogenesis in fibroblasts through two distinct mechanisms: (I) indirectly, via pro-inflammatory and pro-fibrotic mediators released by infected macrophages, and (II) directly, through viral-induced modulation of the Hippo signalling pathway, resulting in upregulation of key fibrotic markers such as CTGF, fibronectin, and collagen I. Conclusions These findings provide novel mechanistic insights into macrophage–fibroblast crosstalk in the context of viral infection and fibrosis. They suggest that dysregulation of these interactions contributes to the susceptibility of the aging lung to fibrotic remodeling following respiratory viral infections and may inform future therapeutic interventions targeting Hippo pathway signalling.